# A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body

> **NCT02538874** · PHASE1 · COMPLETED · sponsor: **Bristol-Myers Squibb** · enrollment: 275 (actual)

## Conditions studied

- Liver Fibrosis/NASH

## Interventions

- **DRUG:** BMS-986171
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT02538874
- **Lead sponsor:** Bristol-Myers Squibb
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-31
- **Primary completion:** 2016-11-04
- **Final completion:** 2016-11-05
- **Target enrollment:** 275 (ACTUAL)
- **Last updated:** 2017-05-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02538874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02538874, "A Study of BMS-986171 in Healthy People to Assess Safety, to Measure Blood Levels of Drug, and to Find Out What the Drug Does to the Body". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02538874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*